USPTO serial 99080255
DOPPELIB
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 25, 2026
- Examiner
- MOLK, DANA L
- Law office
- GENERIC WEB UPDATE
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DOPPELIB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey H. Handelsman
Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.1950 Roland Clarke PlaceReston, VA 20191-1411United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Biomanufacturing for others, namely, contract-based purification of antibodies; Biomanufacturing for others, namely, selection and purification of antibodies; Biomanufacturing for others, namely, selection and purification of proteins; Custom manufacturing of cell lines for laboratory, research and development, or medical purposes; Custom manufacturing of cell lines for antibody production; Custom manufacturing of cell lines; Biomanufacturing for others, namely, biomanufacturing of biological cultured tissues for medical, laboratory, or research and development purposes; Biomanufacturing for others, namely, biomanufacturing of biological cultured tissues; Biomanufacturing for others, namely, contract-based biomanufacturing of biological preparations in the nature of proteins; Processing of biological pharmaceutical preparations for others; Treatment of biological pharmaceutical preparations for others; Biomanufacturing for others, namely, selection and purification of biological preparations in the nature of proteins; Contract-based biomanufacturing in the field of pharmaceuticals; Biomanufacturing for others, namely, selection and purification of pharmaceuticals; Biomanufacturing for others, namely, selection and purification of pharmaceutical preparations; Cryogenic preservation of biological tissues; Custom manufacturing of dietary supplements for humans; Food processing; Dietetic food and drink processing; Preservation of antibodies for scientific and medical research and development | ACTIVE | — |
| 042 | Product research and development services for others in the fields of proteins, antibodies, microorganisms and cells for medical use and consultancy relating thereto; Quality management services, namely, quality control in the fields of proteins, antibodies, microorganisms and cells for medical use and consultancy relating thereto; Research and development services in the field of antibody development technology; Research and development services in the field of antibody technology; Biomedical research services; Design and development of medical technology; Research and development in the field of biotechnology; Pharmaceutical research and development; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations; Scientific research in the nature of conducting clinical trials for others; Technical research services, namely, conducting technical project studies in the field of antibody development technology; Technical research in the field of antibody development technology; Engineering services, particularly technical project planning in the field of antibody development technology; Research and development of new products for others in the medical, scientific, pharmaceutical, biotechnology, and life sciences fields; Design and development of computer software for use with medical technology; Software design and development in the medical, scientific, pharmaceutical, biotechnology, and life sciences fields; Rental of computer software for controlling and managing patient medical information; Providing temporary use of on-line non-downloadable software for controlling and managing patient medical information; Providing virtual computer systems through cloud computing in the medical, scientific, pharmaceutical, biotechnology, and life sciences fields; Scientific laboratory services relating to the acquisition, isolation and cultivation of antibodies, namely, antibodies or antibody-producing cells with desired properties from a population of cells that produce various antibodies; Scientific laboratory services relating to the screening, isolation and cultivation of antibodies, namely, antibodies or antibody-producing cells with desired properties from a population of cells that produce various antibodies, or the acquisition of antibodies or antibody-producing cells with desired properties; Provision of antibodies for scientific and medical research and development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CHIOME BIOSCIENCE INC.
- Other trademarks owned by CHIOME BIOSCIENCE INC.
- Other trademarks owned by CHIOME BIOSCIENCE INC.
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named DOPPELIB
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 1, 2026 | CHPN | POST PUBLICATION AMENDMENT – NOT ENTERED | — |
| Aug 30, 2026 | APET | ASSIGNED TO PETITION STAFF | — |
| Aug 25, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 25, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 28, 2026 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jul 7, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 7, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 1, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 5, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 5, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 5, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 5, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 5, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 31, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 31, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 31, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 24, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 24, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 24, 2026 | ALIE | ASSIGNED TO LIE | — |
| Feb 18, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 29, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 29, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 29, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 4, 2025 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Dec 4, 2025 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Dec 3, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 3, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 3, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 13, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 12, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 12, 2025 | NWAP | NEW APPLICATION ENTERED | — |